RIMAN MLM Review 2026: Products, Compensation Plan and Expansion

RIMAN was founded in South Korea in 2018, and its independent distributors are called planners. It sells under three brands: ICD for skincare, Botalab for personal care and Lifening for wellness.

Its main selling point is Giant BYoungPool, a Centella asiatica cultivar grown at RIMAN's Jeju Smart Farm. RIMAN says it received 20-year plant variety protection in South Korea in July 2022 and in the United States in September 2025. Its European operations are headquartered in London, with customer service and logistics in the United Kingdom and Germany, and the company says it offers planners training, tools and events.

Use this checklist on RIMAN or any similar company. It ranks nothing. For wider sector context, see our top MLM makeup companies 2026 roundup.

INCELLDERM is the earlier name of RIMAN's skincare line, and ICD is its current short form. A 2025 RIMAN release describes ICD as formally Incellderm, BFH's 2022 US launch story called Incellderm the company's skincare line, and Korean press coverage of a 2025 regulatory case ties the Incellderm brand to RIMAN's Korean entity. All three point to the same range.

Skincare sits under ICD, personal care under Botalab and wellness under Lifening, which RIMAN introduced in Taiwan. A May 2024 BehindMLM review listed US retail prices: cleansers and balms from $25, creams and ampoules up to $110, and supplement boxes at $68 to $90. These are two-year-old US prices, so confirm current prices on the official store for your country.

Product and ingredient claims

RIMAN's own materials make three main claims:

The most detailed published figures come from BehindMLM's May 2024 review of the US. It reported a basic planner membership of $20 and three optional starter kits that differ only in bundled products:

The review also described a purchase rule. If your personal orders pass $1,000 in a month, you must show customer sales covering 70% of the amount above $1,000, or further purchases are blocked. BehindMLM added that the plan and joining costs were not shown to consumers on RIMAN's English site at the time.

Some planners say on BFH's RIMAN page that there is no monthly purchase requirement. These are unverified comments from people who sell the product. A video by a Mexican distributor mentions an annual membership of 400 pesos, about $20, which is also unconfirmed. Official EU and Latin American joining costs are not published in the sources we reviewed, so confirm them on RIMAN's pages for your country before you pay.

The only detailed public breakdown is BehindMLM's May 2024 analysis of the US plan. Plans change, and EU and Latin American versions may differ, so treat these figures as a guide and ask RIMAN for the current plan document.

RIMAN runs a rank-based plan with seven ranks, and its team residuals use a unilevel structure. In a unilevel plan, everyone you personally sponsor sits on your first level, however the team grows beneath them. Retail commission on customer orders and the rebate on a planner's own purchases follow the same rate, set by rank:

Example: a Manager who sells $1,000 of product to retail customers earns a $250 retail commission at the 25% rate. A Planner selling the same amount earns $100. This is an illustration of the published rates, not an earnings estimate.

The retail rate caps at 45% from Team Leader upward, so higher ranks earn more through team bonuses, not a higher retail rate. Volume is counted at about 90% of the dollar value spent, per RIMAN as relayed by BehindMLM. Personal group volume covers you and the planners you recruit directly. Group volume covers your whole downline.

On top of retail margin, the plan pays four team bonuses:

RIMAN has not published an earnings disclosure for any market that we could find.

South Korea

On 8 May 2025, Korea's Fair Trade Commission took action against RIMAN Korea Co. (㈜리만코리아), the company behind the Incellderm and Botalab brands, according to Korean press reports (News Seoul, CNC News). The reports say it paid commissions across three or more tiers without registering as a multi-level seller, and let unregistered people sell for it.

The Commission issued corrective orders and decided to refer the company and its former chief executive to prosecutors. The reports mention no fine and put sales at 174.7 billion won, with about 83,000 sellers. This concerns the Korean entity under Korean law, not RIMAN's EU or Latin American operations, and it rests on press coverage rather than the Commission's own release.

Singapore

A 2025 reviewer on BFH said RIMAN was penalised in Korea and might face action in Singapore. The Korean part is covered above. We found no Singapore regulator announcement about RIMAN, so the Singapore claim is unconfirmed. For background, Singapore's Multi-level Marketing and Pyramid Selling (Prohibition) Act bans promoting or joining such schemes unless an exclusion order applies. That describes Singapore's law, not a finding about RIMAN.

EU and Latin America

We found no regulator announcement about RIMAN in France, Germany, Romania, the UK, Ireland, Spain, Italy or the Latin American markets.

RIMAN's 22-market expansion is confirmed only by its own press release, and we found no independent clinical support for its product claims. Earnings data comes from third-party estimates, since RIMAN has published no disclosure of its own. The 2025 Korean action concerned the Korean entity, not the new markets. If you are thinking of joining, get the local registration, costs and refund terms in writing before you pay.

For companies building their own plan, the MLM software behind it should handle ranks, group volume, matching bonuses and leadership pools cleanly.